M

MaxCyte, Inc.

130 employees

MaxCyte specializes in cell modification technologies that enable the discovery, development, and manufacture of various classes.

Basic info

Industry

biotechnology research

Sectors

Medical Device
Biotechnology
Vaccine Development
MyExpertPlatform
Gene Therapy
CARMA
Bispecifics
Protein Production
Electroporation
Stem Cell
Cell Therapy
Immuno-oncology
Gene Editing
Life Sciences
Innovation
Transfection
Immunotherapy
NKcell
Tcell
Cell Engineering
Cancer Research
Manufacturing
Cancer

Date founded

1999

Funding rounds raised

Total raised

$11M

from 2 investors over 2 rounds

M

MaxCyte, Inc. raised $11M on March 24, 2004

Investors: Tall Oaks Capital and Intersouth Partners

FAQ